Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RGS5 gene and therapeutic response to short acting bronchodilators in paediatric asthma patients.

Pediatric pulmonology - 1 Oct 2013

Labuda Malgorzata, Laberge Sophie, Brière Julie, Bérubé Denis, Krajinovic Maja

Abstract excerpt

Short-acting β2-adrenergic receptor agonists are commonly used bronchodilators for symptom relief in asthmatics. Recent evidence demonstrated that prolonged exposure of cultured airway smooth muscle cells to β2 agonists directly augments procontractile signaling pathways with the change in expression of regulator of G protein signaling 5 (RGS5). The aim of this study was to test whether genetic variants in RGS5...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Albuterol
Share to Asthma
Share to Bronchodilator Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Forced Expiratory Volume

Share to RGS Proteins

Share to Treatment Outcome

Source

Identifiers

PMID: 23193110
DOI: 10.1002/ppul.22723

Genes

RGS5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RGS5 gene and therapeutic response to short acting bronchodilators in paediatric asthma patients.PMID 23193110Read ↗

Updated analysis of the pharmacogenomics of pediatric bronchodilator response.Semantic proximity Read ↗

Regulator of G-protein signaling 2 repression exacerbates airway hyper-responsiveness and remodeling in asthma.Semantic proximity Read ↗

Pharmacogenetics of asthma.Semantic proximity Read ↗

Genome-wide association analysis in asthma subjects identifies SPATS2L as a novel bronchodilator response gene.Semantic proximity Read ↗

β2 Agonists.Semantic proximity Read ↗

Pharmacogenomics of long-acting β2-agonists.Semantic proximity Read ↗

GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol.Semantic proximity Read ↗

Understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma – an updateSemantic proximity Read ↗

An RGS4-mediated phenotypic switch of bronchial smooth muscle cells promotes fixed airway obstruction in asthma.Semantic proximity Read ↗

Pharmacogenetics of Bronchodilator Response: Future Directions.Semantic proximity Read ↗

Association analysis of RGS7BP gene polymorphisms with aspirin intolerance in asthmatic patients.Semantic proximity Read ↗

Clinical and molecular implications of RGS2 promoter genetic variation in severe asthma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.